24
Participants
Start Date
September 29, 2021
Primary Completion Date
May 16, 2022
Study Completion Date
May 23, 2022
ACD856
Multiple daily oral doses of ACD856 will be administered for 7 days in an escalation scheme of dose 1, dose 2 and dose 3. The escalation schedule may be adapted based on evaluation by the internal Safety Review Committee.
Placebo
Placebo oral solution
Uppsala University Hospital, Uppsala
Lead Sponsor
AlzeCure Pharma
INDUSTRY